Cary Street Partners Investment Advisory’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SIMG
CAM
BTW
MMC
Cary Street Partners Investment Advisory's HALO Position: Q2 2026 in Review
Cary Street Partners Investment Advisory increased its Halozyme (HALO) stake by 43% in Q2 2026, buying an estimated $3.55K and bringing the position to 173 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #680.
Cary Street Partners Investment Advisory first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.88M in Q3 2024. 343 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Cary Street Partners Investment Advisory held 173 shares of Halozyme worth $13.5K as of Q2 2026.
- Cary Street Partners Investment Advisory bought 52 Halozyme shares in Q2 2026, an estimated $3.55K.
- Halozyme made up ﹤0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #680 holding.
- Cary Street Partners Investment Advisory first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
- Cary Street Partners Investment Advisory's Halozyme position peaked at $6.88M in Q3 2024.
- 343 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.